Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,489 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (403)

clinicaltrialsPublishedShowing 801–850 of 1,275 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05171309	Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC	unknown	Phase 2	35	Nanfang Hospital, Southern Medical UniversityOTHER	1	Dec 28, 2021	clinicaltrials
NCT05166772	Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma	unknown	Phase 2	30	Tianjin Medical University Cancer Institute and HospitalOTHER	0	Dec 22, 2021